SEC reporting owner

TRAINOR III EUGENE A SEC insider disclosures

Explore TRAINOR III EUGENE A's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001172932
Issuers
17
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

INTERCELL USA, INC.0001125001IOMINoNo
TARGACEPT INC0001124105TRGTNoNo
Transcept Pharmaceuticals Inc0001178711NOVC, TSPTNoNo
VONAGE HOLDINGS CORP0001272830VGNoNo
INNERWORKINGS INC0001350381INWKNoNo
HEMOSENSE INC0001127393HEMNoNo
SOURCEFIRE INC0001168195FIRENoNo
GLU MOBILE INC0001366246GLUUNoNo
AMICUS THERAPEUTICS INC0001178879FOLDNoNo
Data Domain, Inc.0001391984DDUPNoNo
Neutral Tandem Inc0001292653TNDMNoNo
PEPLIN INC0001408808PLINNoNo
ARYx Therapeutics, Inc.0001410064ARYXNoNo
SUNESIS PHARMACEUTICALS INC0001061027SNSSNoNo
PHARMOS CORP0000713275PARSNoNo
Echo Global Logistics, Inc.0001426945ECHONoNo
INHIBITEX, INC.0001274913INHXNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.